Irreversible papillitis and ophthalmoparesis as a presenting manifestation of neurobrucellosis

Clinical Neurology and Neurosurgery

Volumn 109, Issue 5, 2007, Pages 439-441

  Miyares, Francisco Ruiz ^a   Deleu, Dirk ^a   ElShafie, Sittana S ^a   Equia, Frank ^a   Mesraoua, Boulenouar ^a   Al Hail, Hassan ^a   Salim, Khalid ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Meningitis; Neurobrucellosis; Ophthalmoparesis; Optic atrophy; Optic neuritis; Papilledema; Papillitis

Indexed keywords

CEFTRIAXONE; DOXYCYCLINE; RIFAMPICIN; STEROID; STREPTOMYCIN;

ADD ON THERAPY; ADULT; ARTICLE; BACTERIAL MENINGITIS; BLOOD CHEMISTRY; BLURRED VISION; BRUCELLOSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; HUMAN; LABORATORY TEST; MALE; MENINGISM; NEUROBRUCELLOSIS; NEUROLOGIC EXAMINATION; OPHTHALMOPLEGIA; OPTIC NERVE ATROPHY; PAPILLITIS; PHYSICAL EXAMINATION; SEROLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; DIAGNOSIS, DIFFERENTIAL; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; MENINGITIS, BACTERIAL; OPHTHALMOPLEGIA; OPTIC ATROPHY; PAPILLEDEMA; RIFAMPIN; STREPTOMYCIN;

EID: 34247477306     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.01.010     Document Type: Article

References (12)

1. McLean D.R., Russell N., and Khan M.Y. Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis 15 (1992) 582-590
2. Young E.J. Brucella species. In: Mandel G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases (2002), Churchill Livingstone, Philadelphia 2386-2393
3. Korman S., Srugo I., Tal Y., Jaffe M., Cahane Z., and Wellish G. Subacute meningitis caused by Brucella: a diagnostic challenge. Eur J Pediatr 148 (1988) 120-121
4. Namiduru M., Karaoglan I., and Yilmaz M. Guillain-Barre syndrome associated with acute neurobrucellosis. Int J Clin Pract 57 (2003) 919-920
5. Gungur K., Bekir N.A., and Namiduru M. Ocular complications associated with brucellosis in an endemic area. Eur J Ophthlalmol 12 (2002) 232-237
6. Elrazak M.A. Brucella optic neuritis. Arch Intern Med 151 (1991) 776-778
7. Karakurum Goksel B., Yerdelen D., Karatas M., et al. Abducens nerve palsy and optic neuritis as initial manifestation in brucellosis. Scand J Infect Dis 38 (2006) 721-725
8. Araj G.F., Lulu A.R., Saadah M.A., Mousa A.M., Strannegard I.L., and Shakir R.A. Rapid diagnosis of central nervous system brucellosis by ELISA. J Neuroimmunol 12 (1986) 173-182
9. Tunç M., and Durukan H. Bilateral severe visual loss in brucellosis. Ocul Immunol Inflamm 12 (2004) 233-236
10. Romero M., Sanchez F., Fernandez-Bolanos R., and Jimenez M.D. Optic neuritis as a clinical manifestation of neurobrucellosis. Rev Neurol 28 (1999) 438
11. Yilmaz M., Ozaras R., Mert A., Ozturk R., and Tabak F. Abducent nerve palsy during treatment of brucellosis. Clin Neurol Neurosurg 105 (2003) 218-220
12. Al Deeb S.M., Yaqub B.A., Sharif H.S., and Phadke J.G. Neurobrucellosis: clinical characteristics, diagnosis and outcome. Neurology 39 (1989) 498-501